Clinical Trial Update: To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 trial to assess the relative bioavailability of ondansetron HCl 24 mg tablets under fasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea
• Vomiting

Drugs mentioned

• Ondansetron HCl 24 mg Tablets (ondansetron)

Snippet

Sponsor: Sandoz | Conditions: Nausea, Vomiting | Phase 1 | Status: COMPLETED